| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_397384a6d230e34cf9e18e9c7d9b0a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eddba5db49659b527d67801ac07801c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c979f821b40a0fb85a375805d23957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473ad3a61990ba15b31b2481d4559dc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df93c3f5b2013f90b704255d41e777e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67361fcb08c712942f024b33f7c67a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a49bbf89ab2d627d21e2936eae3030 |
| publicationDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110621693-A |
| titleOfInvention |
Antigen receptors and their uses |
| abstract |
The present invention generally relates to the treatment of diseases by targeting cells that express antigens on the cell surface. In particular, the present invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors can be used to treat diseases characterized by the expression of one or more antigens that are bound by the antigen receptors. |
| priorityDate |
2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |